Bcl-2, survivin and variant CD44 v7-v10 are downregulated and p53 is upregulated in breast cancer cells by progesterone: Inhibition of cell growth and induction of apoptosis

Molecular and Cellular Biochemistry

Volumn 202, Issue 1-2, 1999, Pages 53-61

  Formby, B ^a   Wiley, T S ^a  

^a SANSUM DIABETES RESEARCH INSTITUTE   (United States)

Author keywords

Anti apoptotic genes; Apoptosis; Breast cancer cells; Progesterone

Indexed keywords

ANNEXIN; CD44V ANTIGEN; PHOSPHATIDYLSERINE; PROGESTERONE; PROGESTERONE RECEPTOR; PROPIDIUM IODIDE; PROTEIN BCL 2; PROTEIN P53; SURVIVIN;

APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CELL PROLIFERATION; CYTOFLUOROMETRY; DOWN REGULATION; GROWTH INHIBITION; HUMAN; HUMAN CELL; NECROSIS; PROTO ONCOGENE;

EID: 0033378988     PISSN: 03008177     EISSN: None     Source Type: Journal    
DOI: 10.1023/a:1007081021483     Document Type: Article

References (37)

1. Darzynkiewicz ZG et al.: Cytometry in cell necrobiology: Analysis of apoptosis and accidental cell death (necrosis) Cytometry 27: 1-20, 1997
2. Jacobson MD, Burne JF, Raff MC: Programmed cell death and Bcl-2 protection in the absence of a nucleus. EMBO J 13: 1899-1903, 1994
3. Vermes L et al.: A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. J Immunol Meth 184: 39-51, 1995
4. Reed JC: Bcl-2 and the regulation of programmed cell death. J Cell Biol 124: 1-6, 1994
5. Chen X, Ko LJ, Jayaraman L, Prives C: p53 levels, functional domain, and DNA damage determine the extent of the apoptotic response of tumor cells. Genes & Develop 10: 2438-2451, 1996
6. Hockenbery DM et al.: Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 75: 241-251, 1993
7. Ambrosini G et al.: A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nature Med 3: 917-921, 1997
8. Lu C-D et al.: Expression of a novel anti-apoptosis gene, survivin, correlated with tumor cell apoptosis and p53 accumulation in gastric carcinoma. Cancer Res 58: 1808-1812, 1998
9. Screaton GR et al.: Genomic structure of DNA encoding the lymphocyte homing factor CD44 reveals at least 12 alternative spliced exons. Proc Natl Acad Sci (USA) 89: 12160-12164, 1992
10. Sabourin JC et al.: Bcl-2 expression in normal breast tissue during menstrual cycle. Int J Cancer 59: 1-6, 1994
11. Gompel A et al.: Bcl-2 expression in normal endometrium during the menstrual cycle. Am J Pathol 144: 1195-1202, 1994
12. Gompel A et al.: Progestin effect on cell proliferation and 17β-hydroxysteroid dehydrogenase activity in normal human breast cells in culture. J Clin Endocrinol Metab 63: 1174-1180, 1986
13. Kandouz M et al.: Antagonism between estradiol and progestin on bcl-2 expression in breast-cancer cells. Int J Cancer 68: 120-125, 1996
14. Takahashi K et al.: Protein synthesis-dependent cytoplasmatic translocation of p53 protein after serum stimulation of growth-arrested MCF-7 cells. Mol Carcinog 8: 58-66, 1993
15. Haldar S et al.: Down-regulation of bcl-2 by p53 in breast cancer cells. Cancer Res 54: 2095-2097, 1994
16. Miyashita T et al.: Identification of a p53-dependent negative response element in the bcl-2 gene. Cancer Res 54: 3131-3135, 1994
17. Miyashita T et al.: Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene 9: 1799-1805, 1994
18. Levine AL: p53, the cellular gatekeeper for growth and division. Cell 88: 323-331, 1997
19. Horwitz KB, Mockers MB, Lessey BA: Variant T47-D human breast cancer cells with high progesterone-receptor levels despite estrogen and anti-estrogen resistance. Cell 28: 633-642, 1982
20. Alderson MR et al.: Fas ligand mediates activation-induced cell death in human T lymphocytes. J Exp Med 181: 71-77, 1995
21. Formby B, Stern R: Phosphorylation stabilizes alternatively spliced CD44 mRNA transcripts in breast cancer cells: Inhibition by antisense complementary to casein kinase II mRNA. Mol Cell Biochem 187: 23-31, 1998
22. Sherman BM, Korenman SG: Inadequate corpus luteum function: A pathophysiological interpretation of human breast cancer epidemiology. Cancer 33: 1306-1312, 1974
23. Cowan LD et al.: Breast cancer incidence in women with a history of progesterone deficiency. Am J Epidemiol 114: 209-217, 1981
24. Vignon F et al.: Antioestrogenic effect of R5020, a synthetic progestin in human breast cancer cells in culture. J Clin Endocrinol Metab 56: 1124-1130, 1984
25. Horwitz KB, Freidenberg GR: Growth inhibition and increase of insulin receptors in antiestrogen-resistant T47Dco human breast cancer cells by progestins: Implications for endocrine therapies. Cancer Res 45: 167-172, 1985
26. Chang K et al.: Influences of percutaneous administration of estradiol and progesterone on human breast epithelial cell cycle in vivo. Fertil Steril 63: 785-791, 1995
27. Foidart JM et al.: Estradiol and progesterone regulate the proliferation of human breast epithelial cells. Fertil Steril 69: 963-969, 1998
28. Barrat J, De Lignieres B, Marpeau L: Effect in vivo de l'administration locale de progesterone sur l'activité mitotique des galactophores humains. J Gynecol Obstet Biol Reprod 19: 269-274, 1990
29. Jeng MH, Parker CJ, Jordan VC: Estrogenic potential of progestins in oral contraceptives to stimulate human breast cancer cell proliferation. Cancer Res 52: 6539-6546, 1992
30. Jordan VC et al.: The estrogenic activity of synthetic progestins used in oral contraceptives. Cancer 71: 1501-1505, 1993
31. Miyagawa K et al.: Medroxyprogesterone interferes with ovarian steroid protection against coronary vasospasm. Nature Med 3: 324-327, 1997
32. Martin SJ et al.: Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: Inhibition by overexpression of bcl-2 and abl. J Exp Med 182: 1545-1556, 1995
33. Bu SZ et al.: Progesterone induces apoptosis and up-regulation of p53 expression in human ovarian carcinoma cell lines. Cancer 79: 1944-1950, 1997
34. Lee WY, Jin YT, Tzeng CC: Reciprocal expression of bcl-2 and p53 in breast ductal carcinoma. Anticancer Res 16: 3007-3012, 1996
35. Lida N, Bourguignon L: New CD44 splice variants associated with human breast cancer. J Cell Physiol 162: 127-133, 1995
36. Owen GI et al.: Progesterone regulates transcription of the p21WAF1 cyclin-dependent kinase inhibitor gene through Sp1 and CBP/p300. J Biol Chem 273: 10696-10701, 1998
37. Kandouz M et al.: Proapoptotic effects of antiestrogens, progestins and androgen in breast cancer cells. J Steroid Biochem Mol Biol 69: 463-471, 1999